These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29154850)

  • 1. Motor Response Matters: Optimizing Lead Placement Improves Sacral Neuromodulation Outcomes.
    Pizarro-Berdichevsky J; Gill BC; Clifton M; Okafor HT; Faris AE; Vasavada SP; Goldman HB
    J Urol; 2018 Apr; 199(4):1032-1036. PubMed ID: 29154850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is sensory testing during lead placement crucial for achieving positive outcomes after sacral neuromodulation?
    Peters KM; Killinger KA; Boura JA
    Neurourol Urodyn; 2011 Nov; 30(8):1489-92. PubMed ID: 21674596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Onset of Action of Sacral Neuromodulation in Lower Urinary Tract Dysfunction-What is the Optimal Duration of Test Stimulation?
    Jairam R; Drossaerts J; Marcelissen T; van Koeveringe G; van Kerrebroeck P
    J Urol; 2018 Jun; 199(6):1584-1590. PubMed ID: 29291416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraoperative Predictors of Sacral Neuromodulation Implantation and Treatment Response: Results From the ROSETTA Trial.
    Gill BC; Thomas S; Barden L; Jelovsek JE; Meyer I; Chermansky C; Komesu YM; Menefee S; Myers D; Smith A; Mazloomdoost D; Amundsen CL
    J Urol; 2023 Aug; 210(2):331-340. PubMed ID: 37126070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Supervised 3 Weeks Test Phase in Sacral Neuromodulation with a 1-Year Followup.
    Tilborghs S; Van de Borne S; Vaganée D; De Win G; De Wachter S
    J Urol; 2021 Jan; 205(1):206-212. PubMed ID: 32716692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific Changes in Brain Activity during Urgency in Women with Overactive Bladder after Successful Sacral Neuromodulation: A Functional Magnetic Resonance Imaging Study.
    Weissbart SJ; Bhavsar R; Rao H; Wein AJ; Detre JA; Arya LA; Smith AL
    J Urol; 2018 Aug; 200(2):382-388. PubMed ID: 29630979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sacral neuromodulation with an implantable pulse generator in children with lower urinary tract symptoms: 15-year experience.
    Groen LA; Hoebeke P; Loret N; Van Praet C; Van Laecke E; Ann R; Vande Walle J; Everaert K
    J Urol; 2012 Oct; 188(4):1313-7. PubMed ID: 22902022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sacral neuromodulation using the standardized tined lead implantation technique with a curved vs a straight stylet: 2-year clinical outcomes and sensory responses to lead stimulation.
    Vaganée D; Kessler TM; Van de Borne S; De Win G; De Wachter S
    BJU Int; 2019 May; 123(5A):E7-E13. PubMed ID: 30537223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do Patients Discontinue Overactive Bladder Medications after Sacral Neuromodulation?
    Amin K; Moskowitz D; Kobashi KC; Lee UJ; Lucioni A
    J Urol; 2019 May; 201(5):973-978. PubMed ID: 30694936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of ultrasound during electrode implantation for sacral neuromodulation in patients with neurogenic bladder secondary to spinal cord disease: a retrospective study.
    Chen Q; Chen G; He X; Chong T; Zhou J; Zhang J; Han H; Nan N
    Int Urol Nephrol; 2021 Jul; 53(7):1325-1330. PubMed ID: 33743121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-Year Followup Results of a Prospective, Multicenter Study of Patients with Overactive Bladder Treated with Sacral Neuromodulation.
    Siegel S; Noblett K; Mangel J; Bennett J; Griebling TL; Sutherland SE; Bird ET; Comiter C; Culkin D; Zylstra S; Kan F; Berg KC
    J Urol; 2018 Jan; 199(1):229-236. PubMed ID: 28709886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of sacral neuromodulation with the tined lead procedure.
    Marcelissen TA; Leong RK; de Bie RA; van Kerrebroeck PE; de Wachter SG
    J Urol; 2010 Nov; 184(5):1997-2000. PubMed ID: 20850820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sacral neuromodulation in urological indications: the Finnish experience.
    Vaarala MH; Tammela TL; Perttilä I; Luukkonen P; Hellström P
    Scand J Urol Nephrol; 2011 Feb; 45(1):46-51. PubMed ID: 20961268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PNE versus 1st stage tined lead procedure: a direct comparison to select the most sensitive test method to identify patients suitable for sacral neuromodulation therapy.
    Leong RK; De Wachter SG; Nieman FH; de Bie RA; van Kerrebroeck PE
    Neurourol Urodyn; 2011 Sep; 30(7):1249-52. PubMed ID: 21404317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Age and Comorbidities on Use of Sacral Neuromodulation.
    Faris AER; Gill BC; Pizarro-Berdichevsky J; Dielubanza E; Clifton MM; Okafor H; Goldman HB; Moore CK; Rackley RR; Vasavada SP
    J Urol; 2017 Jul; 198(1):161-166. PubMed ID: 28192077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of sacral neuromodulation on urological diseases: a multicentric research project.
    Cardarelli S; D'Elia C; Cerruto MA; Curti P; Ostardo E; Signorello D; Pastorello M; Caleffi G; Molon A; Artibani W
    Urologia; 2012; 79(2):90-6. PubMed ID: 22610844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving clinical outcomes for women with overactive bladder or urinary retention symptoms: a comparison of motor response voltages (1-9 V) during Stage 1 sacral neuromodulation.
    Marinkovic SP; Ford JC
    BJU Int; 2018 Sep; 122(3):472-479. PubMed ID: 29637712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal Lead Positioning in Sacral Neuromodulation: Which Factors Are Related to Treatment Outcome?
    Jairam R; Marcelissen T; van Koeveringe G; van Kerrebroeck P
    Neuromodulation; 2017 Dec; 20(8):830-835. PubMed ID: 28877395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remotely programmed sacral neuromodulation for the treatment of patients with refractory overactive bladder: a prospective randomized controlled trial evaluating the safety and efficacy of a novel sacral neuromodulation device.
    Zhang Y; Zhang P; Tian X; Chen G; Li Y; Zhang Y; Xu Z; Wei Z; Zhang W; Ma L; Shi B; Liao L; Wang J
    World J Urol; 2019 Nov; 37(11):2481-2492. PubMed ID: 30809700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized prospective crossover study of interstim lead wire placement with curved versus straight stylet.
    Jacobs SA; Lane FL; Osann KE; Noblett KL
    Neurourol Urodyn; 2014 Jun; 33(5):488-92. PubMed ID: 23737158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.